Your site has given me a lot of hope as well as key useful information.

~Patient Power survey respondent

Featured Programs

A Myeloma Expert's View on Clinical Trial Participation

When should a myeloma patient consider enrolling in a clinical trial? Dr. John Burke shares his opinion.


Understanding “Different Kinds of Clinical Trials” in Myeloma

A clinical trial may provide a beneficial alternative for myeloma patients, but at what point in the course of treatment is it appropriate to do one? Tune in to find out.


What Clinical Trials Are Available for Myeloma Patients That Are Refractory to Lenalidomide?

In this “Ask the Expert” segment featuring Dr. Robert Orlowski from MD Anderson Cancer Center, he shares information about available treatments and clinical trials for myeloma patients that are refractory to lenalidomide (REVLIMID).


The Multiple Myeloma Health Center is sponsored by the Patient Empowerment Network, which has received support from Celgene and Takeda Oncology.

Join Our Community Register For Events Read Our Latest Blog

Page last updated on March 16, 2018